Country
Full text data for US,EP,CN
Type
Legal Validity
Legal Status
Filing Date
Publication Date
Inventor
Assignee
Click to expand
IPC(Section)
IPC(Class)
IPC(Subclass)
IPC(Group)
IPC(Subgroup)
Agent
Agency
Claims Number
Figures Number
Citation Number of Times
Assignee Number
No. Publication Number Title Publication/Patent Number Publication/Patent Number Publication Date Publication Date
Application Number Application Number Filing Date Filing Date
Inventor Inventor Assignee Assignee IPC IPC
1 UA43727U
METHOD FOR PREVENTING METASTASIZING
Publication/Patent Number: UA43727U Publication Date: 2009-08-25 Application Number: 200903729 Filing Date: 2009-04-16 Inventor: Hrynevych, Yurii Yakymovych   Filchakov, Feodosii Viktorovych   Shumilina, Kateryna Stanislavivna   Lion, Hanna Dariivna   Assignee: NATIONAL INSTITUTE OF CANCER PUBLIC INSTITUTION   IPC: A61K35/28 Abstract: A method for preventing metastasizing comprises the use of tumor-specific transfer factor obtained from lymphocytes sensitized in vivo to the tumor antigens at the peak of the immune response of the rats after intraperitoneal immunization with the live cells of Lewis lung carcinoma. A method for preventing metastasizing comprises the use of tumor-specific transfer factor obtained from lymphocytes sensitized in vivo to the tumor antigens at the peak of the immune response of the rats after intraperitoneal immunization with the live cells of Lewis lung ...More ...Less
2 UA42622U
Method for control of specific cell response on tumor antigen in patients with malignant new growths
Publication/Patent Number: UA42622U Publication Date: 2009-07-10 Application Number: 200902055 Filing Date: 2009-03-10 Inventor: Shvets, Yuliia Viktorivna   Khranovska, Natalia Mykolaivna   Sitko, Valentyna Vitaliivna   Skachkova, Oksana Volodymyrivna   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: G01N33/50 Abstract: Method for control of specific cell response on tumor antigen in patients with malignant new growths includes determination of cytokine profile of lymphocytes after sub-cultivation with tumor antigen. Investigations are carried out after each of four introductions of anti-tumor vaccine and at simultaneous reveal of decrease of secretion of interleukin -4 and increase of interferonin lymphocytes under effect of autologous tumor antigen one predicts positive response on anti-tumor vaccination carried out. Method for control of specific cell response on tumor antigen in patients with malignant new growths includes determination of cytokine profile of lymphocytes after sub-cultivation with tumor antigen. Investigations are carried out after each of four introductions of anti-tumor ...More ...Less
3 UA44239U
METHOD FOR PREDICTION OF EARLY METASTASIS OF OSTEOGENOUS SARCOMA
Publication/Patent Number: UA44239U Publication Date: 2009-09-25 Application Number: 200903998 Filing Date: 2009-04-23 Inventor: Yuhrinov, Oleh Hryhorovych   Chornyi, Volodymyr Serhiiovych   Novak, Olena Myloslavivna   Diedkov, Anatolii Hryhorovych   Korovin, Serhii Ihorovych   Yuhroniva, Liudmyla Hryhorivna   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: G01N33/50 Abstract: Method for prediction of early metastasis of osteogenous sarcoma includes definition of protein agents level defining. The black blood serum is used as the test material
4 UA43728U
METHOD FOR PRODUCING TRANSFER FACTOR SPECIFIC TO CELLS OF XENOGENIC TUMOR
Publication/Patent Number: UA43728U Publication Date: 2009-08-25 Application Number: 200903731 Filing Date: 2009-04-16 Inventor: Hrynevych, Yurii Yakymovych   Filchakov, Feodosii Viktorovych   Shumilina, Kateryna Stanislavivna   Lion, Hanna Dariivna   Assignee: NATIONAL INSTITUTE OF CANCER PUBLIC INSTITUTION   IPC: A61K35/28 Abstract: A method for producing transfer factor specific to the cells of the xenogenic tumor comprises the use of low-molecular extract of the splenocytes. The rats are immunized with the live cells of Lewis lung carcinoma intraperitoneally. The preparation of transfer factor is obtained on Day 14. A method for producing transfer factor specific to the cells of the xenogenic tumor comprises the use of low-molecular extract of the splenocytes. The rats are immunized with the live cells of Lewis lung carcinoma intraperitoneally. The preparation of transfer factor is obtained ...More ...Less
5 UA38369U
METHOD FOR TREATING PATIENTS WITH GASTROINTESTINAL CANCER WITH METASTASES INTO LIVER
Publication/Patent Number: UA38369U Publication Date: 2009-01-12 Application Number: 2008011381 Filing Date: 2008-09-22 Inventor: Khranovska, Nataliia Mykolaivna   Yuhrinov, Oleh Hryhorovych   Suprunenko, Oleksandr Anatoliiovych   Rodzaievskyi, Serhii Oleksiiovych   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: A61M5/00 Abstract: A method for treating the patients with gastrointestinal cancer with metastases into the liver comprises intra-arterial chemotherapy (into the proper hepatic artery). Prior to the endovascular treatment and after the first course of chemotherapy
6 UA44240U
METHOD FOR TREATMENT OF PATIENTS WITH THE OSTEOSARCOMA
Publication/Patent Number: UA44240U Publication Date: 2009-09-25 Application Number: 200903999 Filing Date: 2009-04-23 Inventor: Yuhrinov, Oleh Hryhorovych   Konovalenko, Volodymyr Fedorovy   Chornyi, Volodymyr Serhiiovych   Novak, Olena Myloslavivna   Suprunenko, Oleksandr Anatoliiovych   Diedkov, Anatolii Hryhorovych   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: A61M5/00 Abstract: A method for treatment of patients with the osteosarcoma comprises neoadjuvant intravascular polychemotherapy. The chemopreparations together with the COX-2 inhibitir Dinastatum are administered intra-arterialy.
7 UA42669U
METHOD FOR PREDICTING EFFICACY OF CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER
Publication/Patent Number: UA42669U Publication Date: 2009-07-10 Application Number: 200902720 Filing Date: 2009-03-24 Inventor: Solodiannykova, Oksana Ivanivna   Voit, Nataliia Yuriivna   Dzhuzha, Dmytro Oleksandrovych   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: A61B6/00 Abstract: A method for predicting the efficacy of chemotherapy in the patients with breast cancer comprises the radiological examination. The mammoscintigraphy performed prior to chemotherapy allows for estimating the rate of radiopharmaceutical elimination from the tissue of breast cancer. When the rate exceeds the threshold value A method for predicting the efficacy of chemotherapy in the patients with breast cancer comprises the radiological examination. The mammoscintigraphy performed prior to chemotherapy allows for estimating the rate of radiopharmaceutical elimination from the tissue of breast ...More ...Less
8 UA42672U
METHOD FOR NEOADJUVANT INTRA-ARTERIAL CHEMOTHERAPY IN TREATMENT OF LOCALLY ADVANCED CANCER OF TONGUE
Publication/Patent Number: UA42672U Publication Date: 2009-07-10 Application Number: 200902946 Filing Date: 2009-03-30 Inventor: Yuhrinov, Oleh Hryhorovych   Protsyk, Volodymyr Semenovych   Trembach, Oleksandr Mykhailovych   Korobko, Yevhen Volodymyrovych   Rudenko, Dmytro Mykolaiovych   Petrenko, Liudmyla Ivanivna   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: A61M5/00 Abstract: A method for neoadjuvant intra-arterial chemotherapy in the treatment of the locally advanced cancer of the tongue relates to medicine
9 UA39714U
METHOD FOR EVALUATION OF SPECIFIC CELL RESPONSE BY MEANS OF REACTION OF RETARDATION OF MIGRATION OF LEUKOCYTES IN ONCOLOGICAL PATIENTS AFTER IMPLEMENTATION OF DENDRITOCELLULAR VACCINE THERAPY
Publication/Patent Number: UA39714U Publication Date: 2009-03-10 Application Number: 200811614 Filing Date: 2008-09-29 Inventor: Khranovska, Nataliia Mykolaivna   Sitko, Valentyna Vitaliivna   Skachkova, Oksana Volodymyrivna   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   IPC: G01N33/50 Abstract: Method for evaluation of formation of specific cellular response in oncological patients after implementation of dendritocellular vaccine therapy includes determination of percentage of retardation of migration of leucocytes of peripheral blood by means of polyclonal activator of phytohemagliutin as positive control. Additionally one uses autolytic tumor antigene with which dendrite cells are loaded. At increase of percentage of retardation of migration of leucocytes compared to control values one determines presence of formation of specific cell response with prediction of positive response to vaccine therapy. Method for evaluation of formation of specific cellular response in oncological patients after implementation of dendritocellular vaccine therapy includes determination of percentage of retardation of migration of leucocytes of peripheral blood by means of polyclonal activator ...More ...Less
10 UA84618C2
METHOD FOR TREATING PATIENTS WITH ADVANCED OVARIAN CANCER
Publication/Patent Number: UA84618C2 Publication Date: 2008-11-10 Application Number: 2006013848 Filing Date: 2006-12-26 Inventor: Vorobiova, Liusia Ivanivna   Svintsitskyi, Valentyn Stanisla   Assignee: NATIONAL INSTITUTE OF CANCER PUBLIC INSTITUTION   IPC: A61K31/282 Abstract: The invention relates to medicine
11 UA37073U
METHOD FOR PREDICTING COURSE OF DISEASE IN PATIENTS WITH GASTRIC CANCER
Publication/Patent Number: UA37073U Publication Date: 2008-11-10 Application Number: 200809284 Filing Date: 2008-07-16 Inventor: Halakhin, Kostiantyn Oleksandro   Miasoiedov, Dmytro Volodymyrovy   Bazas, Volodymyr Mykolaiovych   Demash, Dmytro Valeriiovych   Lukianova, Nataliia Yuriivna   Assignee: 'NATIONAL INSTITUTE OF CANCER' PUBLIC INSTITUTION   KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY, ONCOLOGY AND RADIOBIOLOGY OF THE NATIONAL ACADEMY OF SCIENCES OF UKRAINE   IPC: A61B10/00 Abstract: A method for predicting the course of the disease in the patients with gastric cancer comprises immunohistochemical assessment of E-cadherin and β-catenin in the deparaffinized section of cancer samples. The positive reaction with the monoclonals against р53